Supportive Oligonucleotide Therapy (SOT)

SOT is a personalized therapy for cancer, viruses and pathogens, including Lyme disease.

SOT has the ability to bind to a specific gene of interest that controls the cancer cell or pathogen by disrupting the critical process that promotes its survival or growth.

During this therapy, a patient's blood is analyzed and a complementary oligonucleotide sequence is created that is designed to disrupt cell survival or growth. SOT from RGCC Laboratories.

Request information without obligation

Request information without obligation, we will study your case with our medical team to give you an answer as soon as possible.